牛結核診断市場：検査別、用途別-2025-2030年の世界予測

牛結核診断市場は、2023年に8億2,778万米ドルと評価され、2024年には8億8,785万米ドルに達すると予測され、CAGR 7.74%で成長し、2030年には13億9,523万米ドルに達すると予測されています。

牛の結核（bTB）診断は、この人獣共通感染症の効果的な管理と制御を保証する、獣医医療の重要な側面です。bTB診断の範囲は、皮膚テスト、血液検査、分子診断など様々な診断技術を含み、それぞれの方法は精度、コスト、実用性のレベルが異なります。bTB診断薬は、主に獣医学的環境、公衆衛生機関、農業部門において適用され、疾病の監視、制御、根絶が最重要課題となっています。最終用途には、動物病院、診断研究所、農場などが含まれます。

結核診断薬市場は、結核の発生件数の増加、診断技術の進歩、疾病管理に対する政府の取り組みの高まりといった要因の影響を受けています。ポータブル診断プラットフォームやデジタル診断プラットフォームなどの技術的進歩を活用し、迅速で費用対効果が高く、精度の高い診断ツールの開発にビジネスチャンスが生じています。統合された疾病管理システムとリアルタイム診断の需要は、さらなる可能性をもたらします。しかし市場開拓は、先端診断薬の高コスト、規制上のハードル、新興国地域での認知度の低さなどの課題に直面しています。技術革新によるコスト削減と認知度の向上により、これらの限界に対処することが市場拡大を後押しします。

ポイントオブケア検査、バイオマーカー探索、遺伝子検査における技術革新は、研究開発にとって最も有望な分野です。さらに、人工知能を統合して合理化を図り、精度を高めることも有望な手段となります。市場競争は激しく、主要企業は製品ポートフォリオと地理的リーチの拡大に注力しています。市場機会を活用するために、利害関係者は戦略的パートナーシップ、研究開発への投資、認知度向上のための教育キャンペーンに注力すべきです。診断のスピードと精度を高める費用対効果が高く、拡張性の高いソリューションを優先することで、新たな市場セグメントを開拓し、長期的な成長を促進することができます。

市場力学：急速に進化する牛結核診断市場の主要市場インサイトを公開

牛結核診断市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 増加する牛の人口における細菌感染の有病率の増加
  • 政府による牛結核対策への多大な努力
  • 新興国における意識の高まり
• 市場抑制要因
  • 不適切な検査結果に関する問題
• 市場機会
  • 牛結核診断ソリューションの継続的な進歩
  • 動物消費の増加と安全な畜産物への需要の高まり
• 市場の課題
  • 牛結核診断に関連する限界

ポーターの5つの力：牛結核診断市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、牛結核診断市場の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：牛結核診断市場における外部からの影響の把握

外部マクロ環境要因は、牛結核診断市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析牛結核診断市場における競合情勢の把握

牛結核診断市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス牛結核診断市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、牛結核診断市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨牛結核診断市場における成功への道筋を描く

牛結核診断市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 牛の頭数増加に伴う細菌感染の蔓延
    • 牛結核と闘うための政府の重要な取り組み
    • 新興国における意識の高まり
  • 抑制要因
    • 不適切な検査結果に関する問題
  • 機会
    • 牛結核診断ソリューションの継続的な進歩
    • 動物の消費量の増加と安全な動物製品への需要の高まり
  • 課題
    • 牛結核診断に関連する制限
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 牛結核診断市場テスト別

• 分子診断検査
• 血清学的検査
• 伝統的なテスト

第7章 牛結核診断市場：用途別

• ポイントオブケア
• 獣医クリニック

第8章 南北アメリカの牛結核診断市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第9章 アジア太平洋地域の牛結核診断市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第10章 欧州・中東・アフリカの牛結核診断市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第11章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• AsureQuality Australia Pty Ltd.
• Becton, Dickinson and Company
• Bio-Rad Laboratories, Inc.
• BioMerieux S.A.
• Bionote USA Inc.
• Boehringer Ingelheim GmbH
• CZ Vaccines S.A.U.
• Enfer Group
• F. Hoffmann-La Roche AG
• IDEXX Laboratories, Inc.
• Lionex GmbH
• Pall Corporation
• PBD Biotech Ltd.
• Takara Bio Inc.
• Thermo Fisher Scientific Inc.
• Zoetis Inc.

LIST OF FIGURES

• FIGURE 1. BOVINE TUBERCULOSIS DIAGNOSIS MARKET RESEARCH PROCESS
• FIGURE 2. BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TESTS, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TESTS, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. AMERICAS BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 11. AMERICAS BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. UNITED STATES BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 13. UNITED STATES BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. ASIA-PACIFIC BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. ASIA-PACIFIC BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. EUROPE, MIDDLE EAST & AFRICA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. EUROPE, MIDDLE EAST & AFRICA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. BOVINE TUBERCULOSIS DIAGNOSIS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 19. BOVINE TUBERCULOSIS DIAGNOSIS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. BOVINE TUBERCULOSIS DIAGNOSIS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. BOVINE TUBERCULOSIS DIAGNOSIS MARKET DYNAMICS
• TABLE 7. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY MOLECULAR DIAGNOSTIC TESTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY SEROLOGICAL TESTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TRADITIONAL TESTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY POINT-OF-CARE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. AMERICAS BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
• TABLE 15. AMERICAS BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 16. AMERICAS BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 17. ARGENTINA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
• TABLE 18. ARGENTINA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 19. BRAZIL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
• TABLE 20. BRAZIL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 21. CANADA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
• TABLE 22. CANADA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 23. MEXICO BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
• TABLE 24. MEXICO BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 25. UNITED STATES BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
• TABLE 26. UNITED STATES BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 27. UNITED STATES BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 28. ASIA-PACIFIC BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
• TABLE 29. ASIA-PACIFIC BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 30. ASIA-PACIFIC BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 31. AUSTRALIA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
• TABLE 32. AUSTRALIA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 33. CHINA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
• TABLE 34. CHINA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 35. INDIA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
• TABLE 36. INDIA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 37. INDONESIA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
• TABLE 38. INDONESIA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 39. JAPAN BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
• TABLE 40. JAPAN BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 41. MALAYSIA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
• TABLE 42. MALAYSIA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 43. PHILIPPINES BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
• TABLE 44. PHILIPPINES BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 45. SINGAPORE BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
• TABLE 46. SINGAPORE BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 47. SOUTH KOREA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
• TABLE 48. SOUTH KOREA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 49. TAIWAN BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
• TABLE 50. TAIWAN BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 51. THAILAND BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
• TABLE 52. THAILAND BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 53. VIETNAM BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
• TABLE 54. VIETNAM BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 55. EUROPE, MIDDLE EAST & AFRICA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
• TABLE 56. EUROPE, MIDDLE EAST & AFRICA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 57. EUROPE, MIDDLE EAST & AFRICA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 58. DENMARK BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
• TABLE 59. DENMARK BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 60. EGYPT BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
• TABLE 61. EGYPT BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 62. FINLAND BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
• TABLE 63. FINLAND BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 64. FRANCE BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
• TABLE 65. FRANCE BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 66. GERMANY BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
• TABLE 67. GERMANY BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 68. ISRAEL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
• TABLE 69. ISRAEL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 70. ITALY BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
• TABLE 71. ITALY BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 72. NETHERLANDS BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
• TABLE 73. NETHERLANDS BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 74. NIGERIA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
• TABLE 75. NIGERIA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 76. NORWAY BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
• TABLE 77. NORWAY BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 78. POLAND BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
• TABLE 79. POLAND BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 80. QATAR BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
• TABLE 81. QATAR BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 82. RUSSIA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
• TABLE 83. RUSSIA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 84. SAUDI ARABIA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
• TABLE 85. SAUDI ARABIA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 86. SOUTH AFRICA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
• TABLE 87. SOUTH AFRICA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 88. SPAIN BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
• TABLE 89. SPAIN BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 90. SWEDEN BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
• TABLE 91. SWEDEN BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 92. SWITZERLAND BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
• TABLE 93. SWITZERLAND BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 94. TURKEY BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
• TABLE 95. TURKEY BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 96. UNITED ARAB EMIRATES BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
• TABLE 97. UNITED ARAB EMIRATES BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 98. UNITED KINGDOM BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
• TABLE 99. UNITED KINGDOM BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 100. BOVINE TUBERCULOSIS DIAGNOSIS MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 101. BOVINE TUBERCULOSIS DIAGNOSIS MARKET, FPNV POSITIONING MATRIX, 2023

The Bovine Tuberculosis Diagnosis Market was valued at USD 827.78 million in 2023, expected to reach USD 887.85 million in 2024, and is projected to grow at a CAGR of 7.74%, to USD 1,395.23 million by 2030.

Bovine Tuberculosis (bTB) diagnosis is a critical aspect of veterinary healthcare, ensuring effective management and control of this zoonotic disease. The scope of bTB diagnosis encompasses various diagnostic techniques, including skin testing, blood tests, and molecular diagnostics, with each method offering differing levels of accuracy, cost, and practicality. Its necessity lies in preventing the spread of bTB from cattle to humans and other animals, safeguarding both public health and the agricultural economy. bTB diagnostics are applied primarily in veterinary settings, public health institutions, and agricultural sectors where monitoring, controlling, and eradicating the disease are paramount. The end-use scope includes veterinary hospitals, diagnostic laboratories, and farms.

The market for bTB diagnostics is influenced by factors such as increasing incidences of bTB, advancements in diagnostic techniques, and rising governmental initiatives for disease control. Opportunities arise in developing rapid, cost-effective, and highly accurate diagnostic tools, leveraging technological advancements like portable and digital diagnostic platforms. Demand for integrated disease management systems and real-time diagnostics offers further potential. However, market growth faces challenges including the high cost of advanced diagnostics, regulatory hurdles, and limited awareness in developing regions. Addressing these limitations by reducing costs through innovation and increasing awareness can bolster market expansion.

Innovation in point-of-care testing, biomarker discovery, and genetic testing represents the best potential areas for research and development. Additionally, integrating artificial intelligence to streamline and enhance accuracy presents a promising avenue. The market is competitive, with significant players focused on expanding their product portfolios and geographical reach. To capitalize on market opportunities, stakeholders should focus on strategic partnerships, investment in R&D, and education campaigns for awareness. Prioritizing cost-effective, scalable solutions that enhance diagnostic speed and precision can unlock new market segments and drive long-term growth.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Bovine Tuberculosis Diagnosis Market

The Bovine Tuberculosis Diagnosis Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Growing prevalence of bacterial infections in rising cattle population
  • Significant governmental efforts to combat bovine tuberculosis
  • Increasing awareness in emerging economies
• Market Restraints
  • Issues relating to inappropriate test results
• Market Opportunities
  • Ongoing advancements in bovine tuberculosis diagnostic solutions
  • Rising animal consumption and elevated demand for safe animal products
• Market Challenges
  • Limitations associated with bovine tuberculosis diagnosis

Porter's Five Forces: A Strategic Tool for Navigating the Bovine Tuberculosis Diagnosis Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Bovine Tuberculosis Diagnosis Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Bovine Tuberculosis Diagnosis Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Bovine Tuberculosis Diagnosis Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Bovine Tuberculosis Diagnosis Market

A detailed market share analysis in the Bovine Tuberculosis Diagnosis Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Bovine Tuberculosis Diagnosis Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Bovine Tuberculosis Diagnosis Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Bovine Tuberculosis Diagnosis Market

A strategic analysis of the Bovine Tuberculosis Diagnosis Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Bovine Tuberculosis Diagnosis Market, highlighting leading vendors and their innovative profiles. These include AsureQuality Australia Pty Ltd., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., BioMerieux S.A., Bionote USA Inc., Boehringer Ingelheim GmbH, CZ Vaccines S.A.U., Enfer Group, F. Hoffmann-La Roche AG, IDEXX Laboratories, Inc., Lionex GmbH, Pall Corporation, PBD Biotech Ltd., Takara Bio Inc., Thermo Fisher Scientific Inc., and Zoetis Inc..

Market Segmentation & Coverage

This research report categorizes the Bovine Tuberculosis Diagnosis Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Tests, market is studied across Molecular Diagnostic Tests, Serological Tests, and Traditional Tests.
• Based on Application, market is studied across Point-of-care and Veterinary Clinics.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing prevalence of bacterial infections in rising cattle population
    • 5.1.1.2. Significant governmental efforts to combat bovine tuberculosis
    • 5.1.1.3. Increasing awareness in emerging economies
  • 5.1.2. Restraints
    • 5.1.2.1. Issues relating to inappropriate test results
  • 5.1.3. Opportunities
    • 5.1.3.1. Ongoing advancements in bovine tuberculosis diagnostic solutions
    • 5.1.3.2. Rising animal consumption and elevated demand for safe animal products
  • 5.1.4. Challenges
    • 5.1.4.1. Limitations associated with bovine tuberculosis diagnosis
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Bovine Tuberculosis Diagnosis Market, by Tests

• 6.1. Introduction
• 6.2. Molecular Diagnostic Tests
• 6.3. Serological Tests
• 6.4. Traditional Tests

7. Bovine Tuberculosis Diagnosis Market, by Application

• 7.1. Introduction
• 7.2. Point-of-care
• 7.3. Veterinary Clinics

8. Americas Bovine Tuberculosis Diagnosis Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Bovine Tuberculosis Diagnosis Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Bovine Tuberculosis Diagnosis Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. Market Share Analysis, 2023
• 11.2. FPNV Positioning Matrix, 2023
• 11.3. Competitive Scenario Analysis
• 11.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. AsureQuality Australia Pty Ltd.
• 2. Becton, Dickinson and Company
• 3. Bio-Rad Laboratories, Inc.
• 4. BioMerieux S.A.
• 5. Bionote USA Inc.
• 6. Boehringer Ingelheim GmbH
• 7. CZ Vaccines S.A.U.
• 8. Enfer Group
• 9. F. Hoffmann-La Roche AG
• 10. IDEXX Laboratories, Inc.
• 11. Lionex GmbH
• 12. Pall Corporation
• 13. PBD Biotech Ltd.
• 14. Takara Bio Inc.
• 15. Thermo Fisher Scientific Inc.
• 16. Zoetis Inc.